acute lymphocytic leukemia

Showing 1 - 25 of 102

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

BESPONSA Injection 1 mg Special Investigation

Active, not recruiting
  • Acute Lymphocytic Leukemia
    • Tokyo, Japan
      Pfizer
    Jun 20, 2023

    Drug Induced Neuropathy in Children With ALL

    Recruiting
    • Acute Lymphocytic Leukemia
      • Trieste, Friuli Venezia Giulia, Italy
        IRCCS materno infantile Burlo Garofolo
      Mar 31, 2023

      Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

      Not yet recruiting
      • Acute Myelogenous Leukemia
      • +17 more
      • Peripheral Blood Stem Cell Transplant
      • +7 more
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Mar 27, 2023

      Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

      Not yet recruiting
      • Myeloid Malignancies
      • +3 more
      • (no location specified)
      Mar 22, 2023

      Acute Lymphocytic Leukemia Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor (CAR) T Cells)

      Recruiting
      • Acute Lymphocytic Leukemia
      • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
      • Tianjin, Tianjin, China
        Hematology Hospital, Chinese Academy of Medical Sciences
      Feb 5, 2023

      Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

      Active, not recruiting
      • Acute Lymphocytic Leukemia
      • Lymphoma
      • Biological/Genetically Modified T cells
      • Cyclophosphamide-based chemotherapy
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 3, 2023

      Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

      Completed
      • Multiple Myeloma
      • +11 more
      • Pre-biotic foods/drinks
      • Charlottesville, Virginia
        University of Virginia
      Jan 2, 2023

      Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Adrenoleukodystrophy Trial in Denver, Valhalla, Salt Lake City (Human

      Completed
      • Mucopolysaccharidosis I
      • +15 more
      • Human Placental Derived Stem Cell
      • Denver, Colorado
      • +2 more
      Oct 24, 2022

      Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)

      Recruiting
      • Acute Myelogenous Leukemia
      • +4 more
      • Stem cell transplantation
      • +3 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Aug 23, 2022

      B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

      Active, not recruiting
      • B-Lymphoid Malignancies
      • +3 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Aug 1, 2022

      Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati

      Recruiting
      • Relapsed/Refractory Leukemias
      • +4 more
      • Kansas City, Missouri
      • +1 more
      Jul 18, 2022

      Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

      Not yet recruiting
      • Acute Leukemia
      • +4 more
      • Haploidentical hematopoietic cell transplantation (haploHCT)
      • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
      • (no location specified)
      Jul 13, 2022

      Acute Lymphocytic Leukemia Trial (Inotuzumab ozogamicin)

      Not yet recruiting
      • Acute Lymphocytic Leukemia
      • Inotuzumab ozogamicin
      • (no location specified)
      Jul 11, 2022

      Non-hodgkin Lymphoma, Acute Lymphocytic Leukemia Trial in Saint Louis (Duvelisib)

      Recruiting
      • Non-hodgkin Lymphoma
      • Acute Lymphocytic Leukemia
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jun 30, 2022

      Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Beijing (CAR-NK-CD19 Cells)

      Recruiting
      • Acute Lymphocytic Leukemia
      • +2 more
      • CAR-NK-CD19 Cells
      • Beijing, Beijing, China
        Beijing Boren Hospital
      Jun 5, 2022

      Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Fludarabine + Total Marrow Irradiation
      • Indianapolis, Indiana
        Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
      Jun 1, 2022

      Acute Lymphocytic Leukemia Trial in Beijing, Tianjin (LCAR-AIO Cells)

      Recruiting
      • Acute Lymphocytic Leukemia
      • LCAR-AIO Cells
      • Beijing, Beijing, China
      • +1 more
      May 31, 2022

      Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)

      Terminated
      • Acute Lymphocytic Leukemia
      • Adult Lymphoblastic Lymphoma
      • La Jolla, California
      • +3 more
      Apr 26, 2022

      Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)

      Recruiting
      • Blastic Plasmacytoid Dendritic Cell Neoplasm
      • +3 more
      • Gilbert, Arizona
      • +14 more
      Apr 20, 2022

      Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

      Completed
      • Chronic Myelogenous Leukemia
      • +9 more
      • Atlanta, Georgia
        Northside Hospital
      Apr 4, 2022

      Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow

      Terminated
      • Acute Myeloid Leukemia
      • +3 more
      • Indianapolis, Indiana
        Indiana University Melvin & Bren Simon Cancer Center
      Feb 22, 2022

      Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Ambiguous Lineage Leukemia or Lymphoma Trial in Washington, Atlanta,

      Not yet recruiting
      • Acute Lymphocytic Leukemia
      • +3 more
      • Washington, District of Columbia
      • +2 more
      Feb 21, 2022

      Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +6 more
      • Boston, Massachusetts
      • +1 more
      Jan 25, 2022